KLK3 and posterior cortical atrophy: In a prospective multicenter study by Scarsbrook et al., an overall DR of 56% was registered in 104 recurrent PCa patients and of 33% among patients with pre-scan PSA less than 0.2 ng/mL, suggesting a good performance also at very low PSA levels [7].